Navigation Links
FDA Approves Label Update for PREZISTA® to Include 192-Week Data in HIV-1-Infected Adult Patients Starting Treatment
Date:10/21/2011

ResultsThe ARTEMIS study compared the efficacy and safety of PREZISTA/r 800/100 mg once daily (n=343) versus lopinavir/r 800/200 mg total daily dose (n=346) in treatment-naive adults with HIV-1. All patients received a fixed-dose combination of tenofovir and emtricitabine once daily. At 192 weeks, PREZISTA/r was shown to be non-inferior to lopinavir/r. This 192 week analysis showed that:

-- 70% of patients in the PREZISTA/r arm reached an undetectable viral load (less than 50 copies/m.) vs. 61% of patients in the lopinavir/r arm.  Virologic failure was 12% in the PREZISTA/r arm and 15% in the lopinavir/r arm. Statistical superiority of PREZISTA/r over the lopinavir/r regimen was demonstrated in both the intent-to-treat (ITT) and on-protocol (OP) analysis.

-- The most common treatment-related adverse reactions (greater or equal to 5 percent) of moderate intensity (greater or equal to grade 2) among patients in the PREZISTA/r arm vs. lopinavir/r arm were: diarrhea (9 percent vs. 16 percent); headache (7 percent vs. 6 percent); abdominal pain (6 percent vs. 6 percent); and rash (6 percent vs. 7 percent).

About the ARTEMIS StudyARTEMIS (AntiRetroviral Therapy with TMC114 ExaMined In naive Subjects) is an international, randomized, controlled, open-label, non-inferiority, Phase 3 trial that compared the efficacy and safety of PREZISTA/r versus lopinavir/r in treatment-naive HIV-1-infected adult patients with viral load greater than 5,000 copies/mL.

The main objective of the study was to demonstrate non-inferiority of PREZISTA/r versus lopinavir/r in the proportion of patients achieving virologic response, defined as confirmed HIV RNA less than 50 copies/mL. Non-inferiority of PREZISTA/r vs. lopinavir/r was defined as a maximum allowable difference of 12 percent for virologic response, with a one-sided significance level of alpha equal to 0.025.

Important Safety Information PREZISTA does not cure HIV-1 infection or AIDS, and
'/>"/>

SOURCE Janssen Therapeutics, Division of Janssen Products, LP
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. FDA Approves Ferriprox to Treat Patients with Excess Iron in the Body
2. FDA Approves Combination Therapy Juvisync
3. FDA Approves Cialis to Treat Benign Prostatic Hyperplasia
4. FDA Approves Remicade to Treat Ulcerative Colitis in Children Older Than 6 Years
5. FDA Approves Soliris for Rare Pediatric Blood Disorder
6. FDA Approves New Indications for Prolia® (Denosumab) for the Treatment of Bone Loss in Patients With Prostate or Breast Cancer Undergoing Hormone Ablation Therapy
7. FDA Approves Xalkori with Companion Diagnostic for a Type of Late-stage Lung Cancer
8. FDA Approves Firazyr To Treat Acute Attacks of Hereditary Angioedema
9. FDA Approves Adcetris to Treat Two Types of Lymphoma
10. FDA Approves the First Specific Treatment for Scorpion Stings
11. Cardinal Health Board of Directors Approves Cash Dividend, Elects David P. King as Director
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... MISSION, Kan. , Aug. 21, 2014 /PRNewswire-iReach/ ... Information Trust Alliance (HITRUST) under its Common Security ... ScriptPro,s Enterprise Security and Privacy Manager, "We appreciate ... the level of commitment that this certification signifies. ... compliant." ABOUT THE CSF CERTIFICATION PROCESS: ...
(Date:8/21/2014)... N.Y. , Aug. 21, 2014  Henry Schein, Inc. ... health care products and services to office-based dental, animal health ... at two investor conferences in September: , September ... New York , NY at 12:50 p.m. ET , ... Conference in New York , NY at 1:25 ...
(Date:8/21/2014)... 21, 2014  The board of directors of VirtualScopics, ... of clinical trial imaging solutions, today announced that ... officer, effective immediately.  Mr. Groff has held the role ... joined VirtualScopics in January 2006 as an accounting manager ... "When the board of VirtualScopics asked Jim to ...
Breaking Medicine Technology:ScriptPro Achieves HITRUST Certification 2Henry Schein To Present At Two Investor Conferences In September 2VirtualScopics, Inc. Names James Groff Chief Financial Officer 2VirtualScopics, Inc. Names James Groff Chief Financial Officer 3VirtualScopics, Inc. Names James Groff Chief Financial Officer 4
(Date:8/21/2014)... Stevin McNamara’s original approach to guitar music is ... music that has existed in India for centuries. Literally meaning ... scale or some fixed sequence of notes, but is considered ... appropriate time of day or season of the year — ... musician occurs, in its turn creating an unique “sound manifestation” ...
(Date:8/21/2014)... Dotinga HealthDay Reporter THURSDAY, ... achieving orgasms during sex with a regular partner, straight ... study suggests. Using surveys of single people, the Kinsey ... climax about 85 percent of the time during sex, while ... females placed third, achieving orgasm during about 63 percent of ...
(Date:8/21/2014)... HealthDay Reporter THURSDAY, Aug. ... in treating respiratory syncytial virus (RSV), a leading cause of ... major progress in being able to treat human RSV infections ... second only to influenza virus," said study author Dr. John ... College of Medicine in Memphis. "There is no ...
(Date:8/21/2014)... The International and American Associations for Dental Research (IADR/AADR) ... Prevalence Following Five Decades of Decline." This study, by ... Chapel Hill, USA, follows edentulism (tooth loss) over the ... losing teeth and requiring dentures. It is published in ... Dental Research ( JDR ). , The ...
(Date:8/21/2014)... According to the new report “Waterborne Coatings ... PTFE, PVDF, PVDC, & Others), by Application (Architectural, ... & Others) - Global Forecast to 2019” published ... estimated to reach $77,838.71 Million by 2019. , ... spread through 225 Slides and in-depth TOC on ...
Breaking Medicine News(10 mins):Health News:Raga Cycle of Shakti Guitar Follows The Sun 2Health News:Raga Cycle of Shakti Guitar Follows The Sun 3Health News:Study: Men, Lesbians More Likely to Have Orgasms 2Health News:Study: Men, Lesbians More Likely to Have Orgasms 3Health News:New Drug May Fight Serious Respiratory Virus in Infants 2Health News:New Drug May Fight Serious Respiratory Virus in Infants 3Health News:Study shows steep decline in tooth loss, increase in socioeconomic disparities 2Health News:Waterborne Coatings Market worth $77,838.71 Million by 2019 – New Report by MarketsandMarkets 2Health News:Waterborne Coatings Market worth $77,838.71 Million by 2019 – New Report by MarketsandMarkets 3Health News:Waterborne Coatings Market worth $77,838.71 Million by 2019 – New Report by MarketsandMarkets 4
... Hospital investigators have identified childhood cancer survivors who ... in part due to the lifesaving bone marrow ... underscore the need for long-term monitoring and early ... additional health education, researchers said. Among the measures ...
... of a screening urine dipstick to diagnose chronic kidney ... confirm Penn State College of Medicine researchers, who validated ... urine dipsticks have routinely been performed on healthy children ... Sekhar, M.D., assistant professor of pediatrics. "The AAP made ...
... of arthritis is greater for African Americans and Hispanics, ... Centers for Disease Control and Prevention (CDC) report published ... . According to the Arthritis Foundation, these findings suggest ... strategies aimed at arthritis prevention and management, particularly among ...
... ... Zoernack and the Socially Responsible (SRI) Bullion Fund Deploy Equity Long/Short Strategy ... by buying companies with good bottom up fundamentals and sell closely related ... minimizing correlation to the overall markets. In this case, we go long ...
... ... Conference, taking place in Houston, TX April 19, 20 and 21, 2010. Interaction ... Practices" and Best Practices in Learning and Development at Kaiser Permanente. , ... Cambridge, MA (PRWEB) April ...
... , ... launched its BodyTrace eScale and Website to the market. The world,s first GSM-enabled bathroom scale ... company,s web-scale and website represents a new milestone in Health 2.0 to promote the collaboration ... ...
Cached Medicine News:Health News:Research findings underscore needed action to safeguard lungs of young cancer survivors 2Health News:Research findings underscore needed action to safeguard lungs of young cancer survivors 3Health News:Routine screening for pediatric chronic kidney disease is not effective 2Health News:Minorities hit hardest by arthritis 2Health News:Steven Zoernack and The Bullion Fund Deploy Equity Long/Short Strategy with Apple (AAPL) and Research in Motion (RIMM) 2Health News:Steven Zoernack and The Bullion Fund Deploy Equity Long/Short Strategy with Apple (AAPL) and Research in Motion (RIMM) 3Health News:Steven Zoernack and The Bullion Fund Deploy Equity Long/Short Strategy with Apple (AAPL) and Research in Motion (RIMM) 4Health News:Steven Zoernack and The Bullion Fund Deploy Equity Long/Short Strategy with Apple (AAPL) and Research in Motion (RIMM) 5Health News:Steven Zoernack and The Bullion Fund Deploy Equity Long/Short Strategy with Apple (AAPL) and Research in Motion (RIMM) 6Health News:Interaction Associates to Sponsor HCI Talent Management for Health Care Conference 2Health News:Interaction Associates to Sponsor HCI Talent Management for Health Care Conference 3Health News:World's First GSM-Enabled Scale Gets Set for Launch to Help in Weight Loss 2
For the quantitative determination of Glycohemoglobin in blood....
For the quantitative determination of Glycohemoglobin (HbA1) in blood by,cation exchange resin. The test is to be used to monitor long-term glucose,control in diabetes mellitus....
... storage protein for iron. The ferritin molecule ... of heavy and light subunits, which surrounds ... phosphate [1]. Ferritin is synthesized in the ... with major concentrations found in the liver, ...
Rapid turn-around time, results in less than 4 hours...
Medicine Products: